Literature DB >> 2226335

Identification of prolactin-like proteins synthesized by normal murine lymphocytes.

D W Montgomery1, J A LeFevre, E D Ulrich, C R Adamson, C F Zukoski.   

Abstract

Cultured murine lymphoid cells release a PRL-like immunoreactive (IR) protein which may be important in immunity, as anti-PRL antisera inhibit lymphocyte proliferation in vitro. We examined culture supernatants (SNs) and cell lysates from concanavalin A (Con A) activated murine thymocytes to identify these proteins. Western blot analysis of cell lysates revealed three specifically-stained PRL-IRs. A doublet of bands at 35.6 and 33.6 kDa was associated with the particulate fraction of the cell. These PRL-IRs were present in lymphocytes independently of mitogen stimulation. In contrast, a 22 kDa PRL-IR was only produced in mitogen stimulated cells, and was specifically immunoprecipitated with anti-PRL antiserum. In addition, all three PRL-like IRs incorporated 35S-methionine in vitro, indicating that they are synthesized by these cells. Only the 22 kDa PRL-like protein was present in culture medium from stimulated cells, suggesting that this may be the PRL bioactivity previously demonstrated in SNs from murine lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2226335     DOI: 10.1210/endo-127-5-2601

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  10 in total

Review 1.  Mammary gland development in prolactin receptor knockout mice.

Authors:  C J Ormandy; N Binart; P A Kelly
Journal:  J Mammary Gland Biol Neoplasia       Date:  1997-10       Impact factor: 2.673

2.  Structural and functional effects of high prolactin levels on injured endothelial cells: evidence for an endothelial prolactin receptor.

Authors:  C J Merkle; L A Schuler; R C Schaeffer; J M Gribbon; D W Montgomery
Journal:  Endocrine       Date:  2000-08       Impact factor: 3.633

Review 3.  The role of prolactin in mammary carcinoma.

Authors:  Charles V Clevenger; Priscilla A Furth; Susan E Hankinson; Linda A Schuler
Journal:  Endocr Rev       Date:  2003-02       Impact factor: 19.871

4.  Pituitary adenylate cyclase-activating peptide (PACAP) immunolocalization in lymphoid tissues of the rat.

Authors:  F Gaytan; A J Martinez-Fuentes; F Garcia-Navarro; H Vaudry; E Aguilar
Journal:  Cell Tissue Res       Date:  1994-05       Impact factor: 5.249

5.  Immunoendocrine mechanisms in mammary tumor progression: direct prolactin modulation of peripheral and preneoplastic hyperplastic-alveolar-nodule- infiltrating lymphocytes.

Authors:  S C Tsai; G H Heppner
Journal:  Cancer Immunol Immunother       Date:  1994-11       Impact factor: 6.968

6.  Growth hormone augments superoxide anion secretion of human neutrophils by binding to the prolactin receptor.

Authors:  Y K Fu; S Arkins; G Fuh; B C Cunningham; J A Wells; S Fong; M J Cronin; R Dantzer; K W Kelley
Journal:  J Clin Invest       Date:  1992-02       Impact factor: 14.808

7.  Prolactin synthesized and secreted by human peripheral blood mononuclear cells: an autocrine growth factor for lymphoproliferation.

Authors:  P Sabharwal; R Glaser; W Lafuse; S Varma; Q Liu; S Arkins; R Kooijman; L Kutz; K W Kelley; W B Malarkey
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

8.  Prolactin increases CD4/CD8 cell ratio in thymus-grafted congenitally athymic nude mice.

Authors:  G O Gaufo; M C Diamond
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-30       Impact factor: 11.205

Review 9.  Prolactin and breast cancer etiology: an epidemiologic perspective.

Authors:  Shelley S Tworoger; Susan E Hankinson
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-02-02       Impact factor: 2.673

10.  Inclusion of Plasma Prolactin Levels in Current Risk Prediction Models of Premenopausal and Postmenopausal Breast Cancer.

Authors:  Marike Gabrielson; Kumari Ubhayasekera; Bo Ek; Mikael Andersson Franko; Mikael Eriksson; Kamila Czene; Jonas Bergquist; Per Hall
Journal:  JNCI Cancer Spectr       Date:  2018-12-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.